Kanebo Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kanebo Ltd.
Contamination and Raw Material Testing Issues Raised in FDA Warning Letters
FDA investigators are continuing to find contamination problems and inadequate testing, according to 20 warning letters issued in the first half of 2013, as well as a troubling trend of repeat observations at Baxter, Hospira and Apotex. Observers say to expect more sterility concerns in future warning letters, particularly involving mold, as FDA ramps up GMP enforcement at compounding pharmacies.
Kanebo Recalls Rhododenol-Based Skin Brighteners From Asian Markets
As many as 450,000 units under an array of brands are being recalled by Kao Corporation’s Kanebo Cosmetics unit following reports suggesting that the company’s Rhododenol brightening ingredient can leave white blotches on skin.
Kanebo Recalls Rhododenol-Based Skin Brighteners From Asian Markets
As many as 450,000 units under an array of brands are being recalled by Kao Corporation’s Kanebo Cosmetics unit following reports suggesting that the company’s Rhododenol brightening ingredient can leave white blotches on skin.
Digene's Long Road Towards a Blockbuster
After spending a decade developing its technology and product development capabilities, centered on testing for human papillomavirus, the cause of cervical cancer, Digene Corp. is growing its top line and finally gaining visibility. Now, the question is whether it can validate its test clinically and secure its market position, which means dislodging an entrenched cytology infrastructure. If successful, the company could become a superstar. On the other hand, its proprietary position could be undermined by other cervical cancer markers that appear downstream of initial HPV infection and have a higher correlation with disease. And Digene's focus on the HPV product opportunity has limited its efforts in developing its core technology at a time when other companies are dedicating significant resources to similar efforts.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice